XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Ordinary Shares
Share capital and additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Balance at Dec. 31, 2018   $ 80,686 $ (333) $ (68,842) $ 11,511
Balance (in Shares) at Dec. 31, 2018 3,553,714        
Issuance of Ordinary Shares in connection with a Standby Equity Distribution Agreement, net (see Note 15.a.1)   465 465
Issuance of Ordinary Shares in connection with a Standby Equity Distribution Agreement, net (see Note 15.a.1) (in Shares) 158,023        
Share based compensation expenses (see Note 15.a.2)   143 143
Share based compensation expenses (see Note 15.a.2) (in Shares) 20,858        
Issuance of Ordinary Shares related to a Securities Purchase Agreement, net (see Note 15.a.3)   935 935
Issuance of Ordinary Shares related to a Securities Purchase Agreement, net (see Note 15.a.3) (in Shares) 400,000        
Exercise of options   316 316
Exercise of options (in Shares) 125,195        
Other comprehensive income (loss)   100 100
Net income (loss)   (913) (913)
Balance at Dec. 31, 2019   82,545 (233) (69,755) 12,557
Balance (in Shares) at Dec. 31, 2019 4,257,790        
Issuance of Ordinary Shares in connection with a Standby Equity Distribution Agreement, net (see Note 15.a.1)   23 23
Issuance of Ordinary Shares in connection with a Standby Equity Distribution Agreement, net (see Note 15.a.1) (in Shares) 41,090        
Share based compensation expenses (see Note 15.a.2)   77 77
Share based compensation expenses (see Note 15.a.2) (in Shares) 7,665        
Expenses underlying shelf registration   (41) (41)
Warrants underlying loan agreement (see Note 15.a.5)   30 30
Exercise of options   193 193
Exercise of options (in Shares) 84,618        
Other comprehensive income (loss)     (10)   (10)
Net income (loss)   (960) (960)
Balance at Dec. 31, 2020   82,827 (243) (70,715) 11,869
Balance (in Shares) at Dec. 31, 2020 4,391,163        
Share based compensation expenses (see Note 15.a.2)   94 94
Share based compensation expenses (see Note 15.a.2) (in Shares) 7,188        
Expenses underlying shelf registration   (27)     (27)
Exercise of options   119 119
Exercise of options (in Shares) 52,167        
Issuance of Ordinary Shares in connection with Prospectus Supplement (see Note 15.a.4)   1,841 1,841
Issuance of Ordinary Shares in connection with Prospectus Supplement (see Note 15.a.4) (in Shares) 800,000        
Net income (loss)   451 451
Balance at Dec. 31, 2021   $ 84,854 $ (243) $ (70,264) $ 14,347
Balance (in Shares) at Dec. 31, 2021 5,250,518